Valuation : Gland Pharma Limited

Market Cap 474B 4.96B 4.26B 3.99B 3.65B 6.88B 6.9B 47.23B 18.46B 239B 18.63B 18.23B 791B P/E 2027 *
36.1x
P/E 2028 * 29.7x
Enterprise Value 437B 4.57B 3.92B 3.67B 3.36B 6.34B 6.35B 43.5B 17.01B 220B 17.16B 16.79B 728B EV / Sales 2027 *
5.83x
EV / Sales 2028 * 4.97x
Free-Float
48.23%
Yield 2027 *
0.71%
Yield 2028 * 0.78%
1 day+0.32%
1 week+1.46%
Current month+15.18%
1 month+18.78%
3 months+24.91%
6 months+54.89%
Current year+67.41%
1 week 2,776.1
Extreme 2776.1
2,900
1 month 2,376.1
Extreme 2376.1
3,039.8
Current year 1,573.6
Extreme 1573.6
3,039.8
1 year 1,573.6
Extreme 1573.6
3,039.8
3 years 1,277.8
Extreme 1277.8
3,039.8
5 years 861
Extreme 861
4,179.65
10 years 861
Extreme 861
4,350
Manager TitleAgeSince
Director of Finance/CFO - 2019-09-29
Chief Operating Officer - 2026-04-05
Chief Tech/Sci/R&D Officer - 2026-02-17
Director TitleAgeSince
Director/Board Member 78 2026-06-14
Chairman 57 2024-06-09
Director/Board Member 71 2018-02-06
Date Insider Type Main position Quantity % Market Cap.
2/26/25 Buy 2,800 0.0017%
6/28/24 Sell 1,950 0.0012%
6/28/24 Sell 1,400 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%+1.46%+49.56%+83.53% 4.96B
-1.12%-5.49%+60.19%+112.43% 1,048B
-1.57%-0.60%+50.33%+59.86% 640B
-1.81%-1.41%+24.07%+75.98% 456B
-0.10%-3.33%+39.12%+40.11% 362B
+0.16%-2.02%+22.95%+38.01% 295B
+0.30%+0.78%+2.29%+12.40% 255B
-0.76%+0.75%+51.75%+70.45% 236B
+1.65%-0.37%-16.46%-53.63% 204B
+0.52%+3.78%+30.67%+93.68% 185B
Average -0.25%-0.46%+31.45%+53.28% 368.66B
Weighted average by Cap. -0.73%-1.92%+38.69%+65.97%

Financials

2027 *2028 *
Net sales 74.93B 785M 673M 630M 577M 1.09B 1.09B 7.47B 2.92B 37.76B 2.95B 2.88B 125B 85.84B 899M 771M 722M 661M 1.25B 1.25B 8.55B 3.34B 43.26B 3.37B 3.3B 143B
Net income 13.12B 137M 118M 110M 101M 190M 191M 1.31B 511M 6.61B 516M 505M 21.88B 15.95B 167M 143M 134M 123M 231M 232M 1.59B 621M 8.04B 627M 613M 26.6B
Net Debt -37.45B -392M -337M -315M -289M -544M -545M -3.73B -1.46B -18.87B -1.47B -1.44B -62.47B -47.28B -495M -425M -398M -364M -686M -688M -4.71B -1.84B -23.83B -1.86B -1.82B -78.87B
Logo Gland Pharma Limited
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.
Employees
4,332
Date Price Change Volume
26-08-28 2,885.20 +0.41% 88,186
26-08-27 ₹2,873.50 -1.02% 129,706
26-08-26 ₹2,903.20 +2.78% 360,874
26-08-25 ₹2,824.60 +0.82% 139,251
26-08-24 ₹2,801.60 -0.63% 517,520
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,873.50INR
Average target price
2,856.07INR
Spread / Average Target
-0.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GLAND Stock